Matching Items (53)
128573-Thumbnail Image.png
Description

Two distinct monocyte (Mo)/macrophage (Mp) subsets (Ly6Clow and Ly6Chi) orchestrate cardiac recovery process following myocardial infarction (MI). Prostaglandin (PG) E2 is involved in the Mo/Mp-mediated inflammatory response, however, the role of its receptors in Mos/Mps in cardiac healing remains to be determined. Here we show that pharmacological inhibition or gene

Two distinct monocyte (Mo)/macrophage (Mp) subsets (Ly6Clow and Ly6Chi) orchestrate cardiac recovery process following myocardial infarction (MI). Prostaglandin (PG) E2 is involved in the Mo/Mp-mediated inflammatory response, however, the role of its receptors in Mos/Mps in cardiac healing remains to be determined. Here we show that pharmacological inhibition or gene ablation of the Ep3 receptor in mice suppresses accumulation of Ly6Clow Mos/Mps in infarcted hearts. Ep3 deletion in Mos/Mps markedly attenuates healing after MI by reducing neovascularization in peri-infarct zones. Ep3 deficiency diminishes CX3C chemokine receptor 1 (CX3CR1) expression and vascular endothelial growth factor (VEGF) secretion in Mos/Mps by suppressing TGFβ1 signaling and subsequently inhibits Ly6Clow Mos/Mps migration and angiogenesis. Targeted overexpression of Ep3 receptors in Mos/Mps improves wound healing by enhancing angiogenesis. Thus, the PGE2/Ep3 axis promotes cardiac healing after MI by activating reparative Ly6Clow Mos/Mps, indicating that Ep3 receptor activation may be a promising therapeutic target for acute MI.

ContributorsTang, Juan (Author) / Shen, Yujun (Author) / Chen, Guilin (Author) / Wan, Qiangyou (Author) / Wang, Kai (Author) / Zhang, Jian (Author) / Qin, Jing (Author) / Liu, Guizhu (Author) / Zuo, Shengkai (Author) / Tao, Bo (Author) / Yu, Yu (Author) / Wang, Junwen (Author) / Lazarus, Michael (Author) / Yu, Ying (Author) / College of Health Solutions (Contributor)
Created2017-03-03
128532-Thumbnail Image.png
Description

Accumulating data from genome-wide association studies (GWAS) have provided a collection of novel candidate genes associated with complex diseases, such as atherosclerosis. We identified an atherosclerosis-associated single-nucleotide polymorphism (SNP) located in the intron of the long noncoding RNA (lncRNA) LINC00305 by searching the GWAS database. Although the function of LINC00305

Accumulating data from genome-wide association studies (GWAS) have provided a collection of novel candidate genes associated with complex diseases, such as atherosclerosis. We identified an atherosclerosis-associated single-nucleotide polymorphism (SNP) located in the intron of the long noncoding RNA (lncRNA) LINC00305 by searching the GWAS database. Although the function of LINC00305 is unknown, we found that LINC00305 expression is enriched in atherosclerotic plaques and monocytes. Overexpression of LINC00305 promoted the expression of inflammation-associated genes in THP-1 cells and reduced the expression of contractile markers in co-cultured human aortic smooth muscle cells (HASMCs). We showed that overexpression of LINC00305 activated nuclear factor-kappa beta (NF-κB) and that inhibition of NF-κB abolished LINC00305-mediated activation of cytokine expression. Mechanistically, LINC00305 interacted with lipocalin-1 interacting membrane receptor (LIMR), enhanced the interaction of LIMR and aryl-hydrocarbon receptor repressor (AHRR), and promoted protein expression as well as nuclear localization of AHRR. Moreover, LINC00305 activated NF-κB exclusively in the presence of LIMR and AHRR. In light of these findings, we propose that LINC00305 promotes monocyte inflammation by facilitating LIMR and AHRR cooperation and the AHRR activation, which eventually activates NF-κB, thereby inducing HASMC phenotype switching.

ContributorsZhang, Dan-Dan (Author) / Wang, Wen-Tian (Author) / Xiong, Jian (Author) / Xie, Xue-Min (Author) / Cui, Shen-Shen (Author) / Zhao, Zhi-Guo (Author) / Li, Mulin Jun (Author) / Zhang, Zhu-Qin (Author) / Hao, De-Long (Author) / Zhao, Xiang (Author) / Li, Yong-Jun (Author) / Wang, Junwen (Author) / Chen, Hou-Zao (Author) / Lv, Xiang (Author) / Liu, De-Pei (Author) / College of Health Solutions (Contributor)
Created2017-04-10
135993-Thumbnail Image.png
Description
Mammalian olfaction relies on active sniffing, which both shapes and is shaped by olfactory stimuli. Habituation to repeated exposure of an olfactory stimuli is believed to be mediated by decreased sniffing; however, this decrease may be reserved by exposure to novel odorants. Because of this, it may be possible to

Mammalian olfaction relies on active sniffing, which both shapes and is shaped by olfactory stimuli. Habituation to repeated exposure of an olfactory stimuli is believed to be mediated by decreased sniffing; however, this decrease may be reserved by exposure to novel odorants. Because of this, it may be possible to use sniffing itself as a measure of novelty, and thus as a measure of odorant similarity. Thus, I investigated the use of sniffing to measure habituation, cross-habituation, and odorant similarity. During habituation experiments, increases in sniff rate seen in response to odorant presentation decreased in magnitude between the first and second presentations, suggesting of habituation. Some of this reduction in sniff rate increases was revered by the presentation of a novel odorant in cross-habituations. However the effect sizes in cross-habituation experiments were low, and the variability high, forestalling the conclusion that sniffing accurately measured cross-habituation. I discuss improvements to the experimental protocol that may allow for cross-habituation to be more accurately measured using sniffing alone in future experiments.
ContributorsVigayavel, Nirmal (Author) / Smith, Brian (Thesis director) / Sanabria, Federico (Committee member) / Gerkin, Rick (Committee member) / Barrett, The Honors College (Contributor)
Created2015-12